印度孟买疫情高峰期医护人员中新冠病毒抗体的流行情况：一项初步研究。
Prevalence of COVID-19 antibodies in healthcare workers at the peak of the pandemic in Mumbai, India: A preliminary study.
作者信息
Singhal Tanu, Shah Sweta, Naik Reshma, Kazi Amreen, Thakkar Pooja
机构信息
Department of Infection Prevention and Control, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
出版信息
Indian J Med Microbiol. 2020 Jul-Dec;38(3 & 4):461-463. doi: 10.4103/ijmm.IJMM_20_308.
Abstract
Healthcare worker (HCW) infections due to COVID-19 are of serious consequence. Testing for antibodies against COVID-19 in HCWs has been previously recommended. We conducted a serosurvey in HCWs at a private hospital in Mumbai which is treating COVID patients. A total of 244 HCWs were tested. The prevalence of infection in asymptomatic HCWs was 4.3% and in previously symptomatic untested HCWs was 70%. We recommend that HCWs with a previous history of COVID symptoms who were not tested/tested negative by reverse transcription-polymerase chain reaction should be tested for antibodies at least 2 weeks after onset of symptoms.
摘要
医护人员因感染新冠病毒而导致的感染会产生严重后果。此前已建议对医护人员进行新冠病毒抗体检测。我们在孟买一家收治新冠患者的私立医院对医护人员进行了血清学调查。总共对244名医护人员进行了检测。无症状医护人员的感染率为4.3%，此前有症状但未检测的医护人员的感染率为70%。我们建议，有新冠症状既往史但逆转录-聚合酶链反应检测未进行/检测为阴性的医护人员，应在症状出现后至少2周进行抗体检测。
相似文献
1
Prevalence of COVID-19 antibodies in healthcare workers at the peak of the pandemic in Mumbai, India: A preliminary study.印度孟买疫情高峰期医护人员中新冠病毒抗体的流行情况：一项初步研究。
Indian J Med Microbiol. 2020 Jul-Dec;38(3 & 4):461-463. doi: 10.4103/ijmm.IJMM_20_308.
2
SARS-CoV-2 infection among healthcare workers of a gastroenterological service in a tertiary care facility.三级医疗保健机构中胃肠病科医护人员的新型冠状病毒2感染情况。
Arab J Gastroenterol. 2020 Sep;21(3):151-155. doi: 10.1016/j.ajg.2020.07.005. Epub 2020 Jul 21.
3
COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study.意大利那不勒斯一家传染病专科医院医护人员中的 COVID-19：一项横断面监测研究结果。
J Hosp Infect. 2020 Aug;105(4):596-600. doi: 10.1016/j.jhin.2020.06.021. Epub 2020 Jun 18.
4
Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the Pandemic.在大流行早期的 2 家荷兰医院中，有症状的 COVID-19 医护人员的患病率和临床表现。
JAMA Netw Open. 2020 May 1;3(5):e209673. doi: 10.1001/jamanetworkopen.2020.9673.
5
Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.纽约市一家三级学术医院医护人员中新冠病毒 2 型抗体的流行情况。
J Gen Intern Med. 2020 Aug;35(8):2485-2486. doi: 10.1007/s11606-020-05926-8. Epub 2020 Jun 3.
6
Prevalence and Clinical Presentation of COVID-19 among Healthcare Workers at a Dedicated Hospital in India.印度一家专科医院医护人员中新冠病毒病的患病率及临床表现
J Assoc Physicians India. 2020 Dec;68(12):16-21.
7
Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx.布朗克斯医护人员感染新冠病毒的抗体证据。
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1348-1349. doi: 10.1017/ice.2020.437. Epub 2020 Aug 26.
8
SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital.意大利一家直面 COVID-19 前线医院的医护人员中 SARS-CoV-2 的血清学特征。
BMC Pulm Med. 2020 Jul 29;20(1):203. doi: 10.1186/s12890-020-01237-0.
9
COVID-19: What happened to the healthcare workers of a research and teaching hospital in Milan, Italy?新型冠状病毒肺炎：意大利米兰一家教学研究型医院的医护人员情况如何？
Acta Biomed. 2020 Sep 7;91(3):e2020016. doi: 10.23750/abm.v91i3.10361.
10
Prevalence of Flu-like Symptoms and COVID-19 in Healthcare Workers from India.印度医护人员中流感样症状和新冠病毒病的患病率
J Assoc Physicians India. 2020 Jul;68(7):27-29.
引用本文的文献
1
Prevalence of severe acute respiratory syndrome coronavirus 2 spike antibodies in some healthcare settings in Egypt.埃及部分医疗机构中严重急性呼吸综合征冠状病毒2刺突抗体的流行情况。
J Egypt Public Health Assoc. 2022 Jun 4;97(1):11. doi: 10.1186/s42506-022-00106-4.
2
Study of immunogenicity, safety and efficacy of covishield vaccine among health care workers in a tertiary cardiac care centre.在一家三级心脏护理中心的卫生保健工作者中研究 covishield 疫苗的免疫原性、安全性和有效性。
Indian J Med Microbiol. 2022 Apr-Jun;40(2):200-203. doi: 10.1016/j.ijmmb.2022.03.003. Epub 2022 Apr 11.
3
Seropositivity of Anti-SARS CoV2 IgG antibodies in health care workers of an Indian tertiary care hospital during COVID-19.新冠疫情期间，印度一家三级护理医院医护人员中抗新冠病毒2型免疫球蛋白G抗体的血清阳性率
Indian J Med Microbiol. 2022 Apr-Jun;40(2):228-230. doi: 10.1016/j.ijmmb.2022.02.004. Epub 2022 Mar 8.
4
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.2020 年 3 月至 2021 年 8 月期间印度 SARS-CoV-2 血清 IgG 抗体的流行率：系统评价和荟萃分析。
Int J Infect Dis. 2022 Mar;116:59-67. doi: 10.1016/j.ijid.2021.12.353. Epub 2021 Dec 28.
5
Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.医院是否是 COVID19 传播的中心？来自印度南部一家三级医院的医护人员连续血清学调查的结果。
Indian J Med Microbiol. 2022 Jan-Mar;40(1):141-143. doi: 10.1016/j.ijmmb.2021.10.006. Epub 2021 Nov 10.
6
A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.横断面研究：三级保健中心无症状医护人员中 SARS-CoV-2 血清流行率：评估 PPE 指南的影响。
Indian J Med Microbiol. 2021 Oct-Dec;39(4):528-533. doi: 10.1016/j.ijmmb.2021.09.011. Epub 2021 Oct 20.
7
Seropositivity of severe acute respiratory syndrome coronavirus 2 infection among healthcare workers of the Armed Forces medical services, India: A multicentric study.印度武装部队医疗服务部门医护人员中严重急性呼吸综合征冠状病毒2感染的血清阳性率：一项多中心研究。
Med J Armed Forces India. 2021 Jul;77(Suppl 2):S359-S365. doi: 10.1016/j.mjafi.2021.03.020. Epub 2021 Jul 26.
8
COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, India.印度拉贾斯坦邦两个城市非医疗一线办公室工作人员中的新冠病毒血清阳性率
J Family Med Prim Care. 2021 Jun;10(6):2400-2404. doi: 10.4103/jfmpc.jfmpc_2381_20. Epub 2021 Jul 2.
9
Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity.新冠医院医护人员的血清学监测：免疫反应及其持久性。
Cureus. 2021 Mar 21;13(3):e14020. doi: 10.7759/cureus.14020.
10
Persistence of SARS-CoV-2 antibodies beyond 6 months in health care workers in Mumbai.孟买医护人员体内新冠病毒抗体持续超过6个月
Indian J Med Microbiol. 2021 Apr;39(2):267. doi: 10.1016/j.ijmmb.2021.02.003. Epub 2021 Feb 26.
本文引用的文献
1
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.Abbott ARCHITECT SARS-CoV-2 IgG 免疫分析与间接免疫荧光法和病毒微量中和试验的比较性能评估。
J Clin Virol. 2020 Aug;129:104539. doi: 10.1016/j.jcv.2020.104539. Epub 2020 Jul 6.
2
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?新冠康复后临床复发的 COVID-19 症状：病毒复发、再感染还是炎症反弹？
J Infect. 2020 Nov;81(5):816-846. doi: 10.1016/j.jinf.2020.06.073. Epub 2020 Jun 30.
3
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.恒河猴初次接触 SARS-CoV-2 可预防再次感染。
Science. 2020 Aug 14;369(6505):818-823. doi: 10.1126/science.abc5343. Epub 2020 Jul 2.
4
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff.高风险医护人员和医院员工中 SARS-CoV-2 RT-PCR 阳性率和血清阳性率的动态变化。
J Hosp Infect. 2020 Sep;106(1):102-106. doi: 10.1016/j.jhin.2020.06.028. Epub 2020 Jun 25.
5
Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff.临床医护人员中血清 IgG 抗体对 SARS-CoV-2 的流行情况。
PLoS One. 2020 Jun 25;15(6):e0235417. doi: 10.1371/journal.pone.0235417. eCollection 2020.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
7
Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study.中国武汉医护人员预防 2019 年冠状病毒病使用个人防护设备的情况：横断面研究。
BMJ. 2020 Jun 10;369:m2195. doi: 10.1136/bmj.m2195.
8
The right to know: ethical implications of antibody testing for healthcare workers and overlooked societal implications.知情权：医护人员抗体检测的伦理影响及被忽视的社会影响
J Med Ethics. 2020 Jun 3. doi: 10.1136/medethics-2020-106467.
9
Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.Elecsys® Anti-SARS-CoV-2 免疫分析与 EDI™ 酶联免疫吸附试验在人血浆中检测 SARS-CoV-2 抗体的比较。
Clin Chim Acta. 2020 Oct;509:18-21. doi: 10.1016/j.cca.2020.05.049. Epub 2020 May 30.
10
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019（SARS-CoV-2）诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
Zotero 插件